STOCK OPTIONS AND RESTRICTED SHARES (Schedule of Performance-Vesting Restricted Stock and Time Vesting-Restricted Stock) (Details)	12 Months Ended
	Mar. 31, 2024 $ / shares shares
Time Based Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding, beginning of the period (shares) | shares	612,819
Shares issued (shares) | shares	677,090
Shares vested (shares) | shares	(260,555)
Shares forfeited (shares) | shares	(15,250)
Shares outstanding, end of the period (shares) | shares	1,014,104
Balance at March 31, 2023	$ 2.82
Weighted Average Fair Value Price Shares issued	1.42
Weighted Average Fair Value Price Shares vested	3.19
Weighted Average Fair Value Price Shares forfeited	2.01
Shares outstanding at March 31, 2024	1.87
Time Based Restricted Shares [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Per share price on grant date	0.95
Time Based Restricted Shares [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Per share price on grant date	$ 1.55
Performance Based Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding, beginning of the period (shares) | shares	130,635
Shares issued (shares) | shares	577,742
Shares vested (shares) | shares	0
Shares forfeited (shares) | shares	0
Shares outstanding, end of the period (shares) | shares	708,377
Balance at March 31, 2023	$ 2.15
Weighted Average Fair Value Price Shares issued	1.55
Weighted Average Fair Value Price Shares vested	0
Weighted Average Fair Value Price Shares forfeited	0
Shares outstanding at March 31, 2024	1.66
Performance Based Restricted Shares [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Per share price on grant date	1.55
Performance Based Restricted Shares [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Per share price on grant date	$ 2.18